bromocriptine has been researched along with deamino arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lepor, H | 1 |
2 review(s) available for bromocriptine and deamino arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Nonoperative management of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androgen Antagonists; Bromocriptine; Catheterization; Clinical Trials as Topic; Deamino Arginine Vasopressin; Fatty Alcohols; Hormones; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Urethra | 1989 |
1 trial(s) available for bromocriptine and deamino arginine vasopressin
| Article | Year |
|---|---|
Nonoperative management of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androgen Antagonists; Bromocriptine; Catheterization; Clinical Trials as Topic; Deamino Arginine Vasopressin; Fatty Alcohols; Hormones; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Urethra | 1989 |